Acute Pain and Side Effects After Tramadol in Breast Cancer Patients: Results of a Prospective Double-blind Randomized Study

Overview

Journal Sci Rep

Specialty Science

Date 2020 Oct 31

PMID 33127945

Citations 5

Authors

Nikola Besic

Jaka Smrekar

Branka Strazisar

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to evaluate the severity of acute pain and side effects in breast cancer patients postoperatively treated with two regimens of tramadol with paracetamol in a prospective double-blind study. Altogether 117 breast cancer patients who had axillary lymphadenectomy were randomized into two analgesic study groups and the analgesic treatment lasted 4 weeks. Stronger analgesia group received every 8 h 75/650 mg of tramadol with paracetamol, while weaker analgesia group received every 8 h 37.5/325 mg of tramadol with paracetamol. Patients with the higher dose of tramadol had less pain during the 1st and 4th week than patients with the lower dose. Frequency of nausea, vomiting, lymphedema or range of shoulder movement was not significantly different between the two groups of patients. Constipation was significantly more common in the group with stronger analgesia during the 2nd week in comparison to patients with weaker analgesia. The patients who were on 75/650 mg of tramadol with paracetamol had less pain in comparison to patients who were on 37.5/325 mg. Side effects were mild, but common in both groups of patients.

Citing Articles

From Cadaveric Dissection to the Operating Room: A Unilateral Double Intercostobrachial Nerve and the Implications in Axillary Lymph Node Dissection.

Olivencia-Delgado M, Jusino-Alamo J, De Miranda-Sanchez E, Quinones-Rodriguez J Cureus. 2023; 15(3):e36647.

PMID: 37102027 PMC: 10123002. DOI: 10.7759/cureus.36647.

Association of , , and genetic variability with acute pain, chronic pain and adverse effects after postoperative tramadol and paracetamol treatment in breast cancer.

Vidic Z, Goricar K, Strazisar B, Besic N, Dolzan V Radiol Oncol. 2023; 57(1):111-120.

PMID: 36942908 PMC: 10039478. DOI: 10.2478/raon-2023-0003.

Preparation and identification of anti-breast cancer cells peptides released from yak milk casein.

Gu H, Liang L, Zhu Z, Mao X Front Nutr. 2022; 9:997514.

PMID: 36091230 PMC: 9462664. DOI: 10.3389/fnut.2022.997514.

Changes in Pain Sensitivity in Treatment for Breast Cancer: A 12-Month Follow-Up Case Series.

Lorenzo-Gallego L, Arranz-Martin B, Romay-Barrero H, Prieto-Gomez V, Lluch E, Torres-Lacomba M Int J Environ Res Public Health. 2022; 19(7).

PMID: 35409738 PMC: 8998435. DOI: 10.3390/ijerph19074055.

Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells.

Huang Y, Sue S, Wu Z, Huang S, Lee S, Wu Z Front Oncol. 2022; 12:811716.

PMID: 35155248 PMC: 8826738. DOI: 10.3389/fonc.2022.811716.

References

Bravo L, Mico J, Berrocoso E . Discovery and development of tramadol for the treatment of pain. Expert Opin Drug Discov. 2017; 12(12):1281-1291. DOI: 10.1080/17460441.2017.1377697. View

Kelly D, Ahmad M, Brull S . Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth. 2001; 48(10):1000-10. DOI: 10.1007/BF03016591. View

Lloyd R, Hotham E, Hall C, Williams M, Suppiah V . Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl. Pain Med. 2017; 18(12):2369-2387. DOI: 10.1093/pm/pnw317. View

Roussin A, Doazan-dOuince O, Geniaux H, Halberer C . Evaluation of abuse and dependence in addiction monitoring systems: tramadol as an example. Therapie. 2015; 70(2):203-21. DOI: 10.2515/therapie/2015014. View

Na H, Oh A, Koo B, Lim D, Ryu J, Han J . Preventive Analgesic Efficacy of Nefopam in Acute and Chronic Pain After Breast Cancer Surgery: A Prospective, Double-Blind, and Randomized Trial. Medicine (Baltimore). 2016; 95(20):e3705. PMC: 4902427. DOI: 10.1097/MD.0000000000003705. View

Vazzana M, Andreani T, Fangueiro J, Faggio C, Silva C, Santini A . Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother. 2015; 70:234-8. DOI: 10.1016/j.biopha.2015.01.022. View

St Sauver J, Olson J, Roger V, Nicholson W, Black 3rd J, Takahashi P . phenotypes are associated with adverse outcomes related to opioid medications. Pharmgenomics Pers Med. 2017; 10:217-227. PMC: 5533497. DOI: 10.2147/PGPM.S136341. View

Wang L, Guyatt G, Kennedy S, Romerosa B, Kwon H, Kaushal A . Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ. 2016; 188(14):E352-E361. PMC: 5047835. DOI: 10.1503/cmaj.151276. View

Reyad R, Omran A, Abbas D, Kamel M, Shaker E, Tharwat J . The Possible Preventive Role of Pregabalin in Postmastectomy Pain Syndrome: A Double-Blinded Randomized Controlled Trial. J Pain Symptom Manage. 2018; 57(1):1-9. DOI: 10.1016/j.jpainsymman.2018.10.496. View

10.

Petrone D, Kamin M, Olson W . Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial. J Clin Pharm Ther. 1999; 24(2):115-23. DOI: 10.1046/j.1365-2710.1999.00203.x. View

11.

Lucci A, McCall L, Beitsch P, Whitworth P, Reintgen D, Blumencranz P . Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007; 25(24):3657-63. DOI: 10.1200/JCO.2006.07.4062. View

12.

DeLemos B, Richards H, Vandenbossche J, Ariyawansa J, Natarajan J, Alexander B . Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Multiple-Ascending-Dose Study. Clin Pharmacol Drug Dev. 2017; 6(6):592-603. DOI: 10.1002/cpdd.378. View

13.

Strazisar B, Besic N . Comparison of continuous local anaesthetic and systemic pain treatment after axillary lymphadenectomy in breast carcinoma patients - a prospective randomized study. Radiol Oncol. 2013; 47(2):145-53. PMC: 3691083. DOI: 10.2478/raon-2013-0018. View

14.

Besic N, Smrekar J, Strazisar B . Chronic adverse effects after an axillary lymphadenectomy in breast cancer patients after administering weaker and stronger postoperative analgesia: results of a prospective double-blind randomized study. Breast Cancer Res Treat. 2020; 182(3):655-663. DOI: 10.1007/s10549-020-05713-3. View

15.

Amr Y, Yousef A . Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010; 26(5):381-5. DOI: 10.1097/AJP.0b013e3181cb406e. View

16.

Fecho K, Miller N, Merritt S, Klauber-DeMore N, Hultman C, Blau W . Acute and persistent postoperative pain after breast surgery. Pain Med. 2009; 10(4):708-15. DOI: 10.1111/j.1526-4637.2009.00611.x. View

17.

Kumar S, Goel D, Sharma S, Ahmad S, Dwivedi P, Deo N . A randomised controlled study of the post-operative analgesic efficacy of ultrasound-guided pectoral nerve block in the first 24 h after modified radical mastectomy. Indian J Anaesth. 2018; 62(6):436-442. PMC: 6004763. DOI: 10.4103/ija.IJA_523_17. View

18.

Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D . Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003; 79(1):47-57. DOI: 10.1023/a:1023330206021. View

19.

Gartner R, Jensen M, Nielsen J, Ewertz M, Kroman N, Kehlet H . Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009; 302(18):1985-92. DOI: 10.1001/jama.2009.1568. View